The Humana-Aetna deal was one of two mergers that would have reshaped the U.S. health insurance landscape. Both were rejected by federal judges as anticompetitive. Anthem hasn't given up on its deal—a $48 billion pact to acquire Cigna—and is pressing ahead with an appeal.
Anthem filed a notice of appeal on Thursday after a federal judge blocked its $48 billion deal to buy Cigna Corp.
Vice President Mike Pence may have just picked another fight with pharmaceutical companies—one that doesn’t involve drug prices.
The deal, along with Aetna Inc.’s proposed tie-up with Humana Inc., which was blocked last month, was set to reduce the ranks of big U.S. health insurers to three from five and make Anthem the largest by membership.
Companies have spent the last few years beefing up their parental-leave policies to attract and retain the most sought-after workers. Up next in the benefits arms race: helping workers deal with sickness and death.
If a deal occurs, Hudson’s Bay might fold Macy’s assets, worth about $20 billion, into HBS Global Properties, its joint venture with Indianapolis-based Simon Property Group.
Eli Lilly and Co. CEO Dave Ricks said he was encouraged by President Donald Trump’s understanding of the complexities of drug development, yet he’s concerned about risks the industry may face in a fresh overhaul of the U.S. health-care system.
For drugmakers, including Indianapolis-based Eli Lilly and Co., a meeting Tuesday with President Donald Trump was a dose of happy pills.
President Trump took Big Pharma to task on pricing but also promised to ease regulations and find ways to speed medicines to market, which triggered a surge in the sector’s share prices.
President Trump is fulfilling a promise he made shortly after his election to reduce federal regulations. In practice, the policy potentially requires months of study and public input for each regulation eliminated.
It wasn’t a surprise when Donald Trump took the opportunity during his Jan. 11 press conference to angrily accuse CNN of spreading fake news. Throughout the campaign Trump had complained the cable network was being unfair to him—and at one point vowed that as president, he would block AT&T Inc.’s proposed $85.4 billion merger with […]
The leadership change was announced Monday as Liberty Media Corp. completed the $4.4 billion acquisition of Formula One from private equity firm CVC Capital Partners.
French billionaire Vincent Bollore’s push into electric vehicles has been a huge success, at least in terms of publicity and eye-catching contracts. For investors, it hasn’t worked out so well.
From oozing blisters and wheezing to rashes, itchy eyes, and sore throats, numerous flight attendants at one of the country’s largest airlines say their new work uniforms are making them sick.
Navient Corp. has been sued by a U.S. regulator over allegations that the student loan giant failed to properly service private and federal loans. Navient has major operations in Indiana.
The crisis engulfing Pearson Plc deepened Wednesday after the London-based education company cut its profit forecast and predicted years of gloom in the U.S. market. The company has operations in Indianapolis.
Teva Pharmaceuticals Industries Ltd.’s proposed generic version infringes a patent on the multi-billion-dollar patent, the U.S. Court of Appeals for the Federal Circuit ruled.
VCA operates more than 750 animal hospitals in the United States, including about 10 in the Indianapolis area.
The U.S.’s biggest health insurer, UnitedHealth Group Inc., said it will buy Surgical Care Affiliates Inc. for about $2.3 billion, further diversifying by adding an outpatient surgery chain.
Former Indiana Sen. Dan Coats is the front-runner to become Donald Trump’s director of national intelligence, according to two people familiar with the decision.
